Praxis Precision Medicines 'A Diversified Player In Epilepsy Market,' Analyst Sees Over 100% Stock Upside

• click to rate

  Posted by Two Blokes May 7 - Filed in General - #TwoBlokesTrading  - 10 views
  
  Chardan Research initiated coverage on Praxis Precision Medicines, Inc. PRAX on Wednesday, citing the potential of its epilepsy franchise.